MetaCap

Edgewise Therapeutics Balance Sheet

NASDAQ: EWTXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

39.06-0.17 (-0.43%)

At close: Oct 9, 4:00 PM ET · Delayed 15 min

Edgewise Therapeutics financial position

At the end of fiscal 2025, Edgewise Therapeutics reported total assets of $552.6 million, up 13.5% from a year earlier against total liabilities of $30.3 million. Shareholders' equity stood at $522.3 million, or 94.5% of assets. The company held $61.1 million in cash and equivalents.

The current ratio (current assets divided by current liabilities) was 19.85, meaning short-term assets cover obligations due within a year.

Summary generated from market data by MetaCap's automated system. Methodology

Edgewise Therapeutics balance sheet (annual)

Edgewise Therapeutics annual balance sheet
Fiscal year (USD)FY 20252025-12-31FY 20242024-12-31FY 20232023-12-31FY 20222022-12-31FY 20212021-12-31FY 20202020-12-31
Cash & Equivalents61.15M41.67M86.10M21.99M15.57M104.92M
Total Current Assets543.38M475.48M327.00M357.00M283.77M129.65M
Property, Plant & Equipment7.83M9.50M10.44M8.53M912.00K516.00K
Total Assets552.60M486.82M340.04M367.10M285.23M131.14M
Accounts Payable6.01M5.58M4.03M6.11M3.84M1.58M
Total Current Liabilities27.37M23.86M16.77M16.59M10.52M4.34M
Total Liabilities30.35M27.60M21.20M20.39M10.85M4.34M
Shareholders' Equity522.26M459.22M318.83M346.72M274.38M-33.42M
Retained Earnings-546.37M-378.58M-244.76M-144.60M-76.96M-34.15M
Net Cash (Debt)61.15M41.67M86.10M21.99M15.57M104.92M
Shares Outstanding106.25M94.84M70.45M63.26M49.50M1.01M

This table shows 6 annual periods of Edgewise Therapeutics's balance sheet, from FY 2025 back to FY 2020, across 11 line items including cash & equivalents, total current assets, property, plant & equipment. Values in USD; B = billions, M = millions. Fiscal periods follow EWTX's reporting calendar. What is a balance sheet?

More financial data